OLUMIANT (baricitinib) tablets is used for the treatment of patients with rheumatoid arthritis and COVID-19.

Olumiant (baricitinib) blocks the activity of certain enzymes involved in activating inflammation in the body. Olumiant is used to reduce pain, stiffness, and swelling in adults with rheumatoid arthritis after other treatments have failed. Olumiant also helps slow the progression of bone and joint damage.

In November 2020, the FDA issued an Emergency Use Authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized people two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

OLUMIANT (baricitinib) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of OLUMIANT (baricitinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the OLUMIANT (baricitinib) tablets medicine cost price in India.

The order for OLUMIANT (baricitinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Baricitinib is a janus kinase inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation. Baricitinib is a prescription oral tablet medication that is FDA-approved (and sold under the brand name Olumiant) for the treatment of moderately to severely active rheumatoid arthritis. Under today’s EUA, the FDA is authorizing the emergency use of baricitinib, in combination with remdesivir, for the treatment of certain hospitalized patients with suspected or laboratory-confirmed COVID-19.

the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Content Source: FDA NEWS RELEASE

OLUMIANT (baricitinib) tablets, for oral use Initial U.S. Approval: 2018

Generic Name: baricitinib

Olumiant (Baricitinib)

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to Olumiant (Baricitinib) on the Named Patient Import basis in India.

OLUMIANT (baricitinib) tablets

News / Update for OLUMIANT (baricitinib) tablets.

For OLUMIANT (baricitinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Natco rolls out Baricitinib ahead of approval for patent waiver For More Details

Lilly accelerating baricitinib's availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements For More Details

Influenza antiviral OLUMIANT (baricitinib) tablets Manufacturer in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand OLUMIANT (baricitinib) tablets on prescription and Import License in Patient's Name only.

For overseas patients, OLUMIANT (baricitinib) tablets can be made available in Send your enquiry to find OLUMIANT (baricitinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Four steps to access the medicines you need

How and where to buy OLUMIANT (baricitinib) tablets:
You can order Avigan from Indian Pharma Network if the drug has not been approved or is not available in your country.

Step 1
You send a request for your medicine online Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2
We verify your prescription and medical details
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3
We source your medicine
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4
We deliver your medicine
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number :07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 6,000 patients.

Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur